China Pharma Holdings Inc (CPHI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX
Market Cap: $22.29M
Last updated: Nov 17, 2026 at 10:59 AM ET
China Pharma Holdings Inc (CPHI) Earnings: Report Dates and Results
In the quarter ended Jun 30, 2026, China Pharma Holdings reported EPS of -$0.04. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Next Report
CPHI's next report is not on the earnings calendar yet.
Earnings History
Revenue for the quarter ended Jun 30, 2026 was $948340, down 7.9% from $1.03M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2026 | $948340 |
| Sep 30, 2025 | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2025 | $756217 |
| Jun 30, 2025 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2025 | $1.03M |
| Mar 31, 2025 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2025 | $1.14M |
| Dec 31, 2024 | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2025 | $1.13M |
| Sep 30, 2024 | -$0.65 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 18, 2024 | $1.10M |
| Jun 30, 2024 | -$0.89 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2024 | $924943 |
| Mar 31, 2024 | -$0.73 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 1, 2024 | $1.37M |
| Dec 31, 2023 | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 28, 2024 | $2.15M |
| Sep 30, 2023 | -$2.94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2023 | $1.80M |
| Jun 30, 2023 | -$2.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2023 | $1.10M |
| Mar 31, 2023 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2023 | $1.96M |
| Dec 31, 2022 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2023 | $2.92M |
| Sep 30, 2022 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2022 | $1.97M |
| Jun 30, 2022 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2022 | $1.61M |
| Mar 31, 2022 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2022 | $1.60M |
| Dec 31, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2022 | $2.89M |
| Sep 30, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | $1.98M |
| Jun 30, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2021 | $2.42M |
| Mar 31, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2021 | $2.36M |
| Dec 31, 2020 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 26, 2021 | $2.93M |
| Sep 30, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2020 | $2.40M |
| Jun 30, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2020 | $3.77M |
| Mar 31, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 | $1.76M |
| Dec 31, 2019 | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 26, 2020 | $3.05M |
| Sep 30, 2019 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2019 | $2.38M |
| Jun 30, 2019 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 15, 2019 | $2.57M |
| Mar 31, 2019 | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2019 | $2.93M |
| Dec 31, 2018 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2019 | $3.24M |
| Sep 30, 2018 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2018 | $2.30M |
| Jun 30, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 15, 2018 | $3.17M |
| Mar 31, 2018 | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 3, 2018 | $3.62M |
| Dec 31, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2018 | $3.85M |
| Sep 30, 2017 | -$0.05 | N/A | N/A | N/A | N/A | -162.5% | N/A | N/A | Nov 15, 2017 | $3.16M |
| Jun 30, 2017 | -$0.05 | N/A | N/A | N/A | N/A | -162.5% | N/A | N/A | Aug 15, 2017 | $2.92M |
| Mar 31, 2017 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2017 | $3.29M |
| Dec 31, 2016 | -$0.02 | N/A | N/A | N/A | N/A | -127.7% | N/A | N/A | Mar 31, 2017 | $5.26M |
| Sep 30, 2016 | $0.08 | N/A | N/A | N/A | N/A | 0.0% | N/A | N/A | Nov 15, 2016 | $3.13M |
| Jun 30, 2016 | $0.08 | N/A | N/A | N/A | N/A | +18.9% | N/A | N/A | Aug 11, 2016 | $3.54M |
| Mar 31, 2016 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 17, 2016 | $3.64M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$2.80, after -$7.15 the year before. It was $0.13 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$2.80 | N/A |
| Dec 31, 2023 | -$7.15 | N/A |
| Dec 31, 2022 | -$0.26 | N/A |
| Dec 31, 2021 | -$0.08 | N/A |
| Dec 31, 2020 | -$0.09 | N/A |
| Dec 31, 2019 | -$0.64 | N/A |
| Dec 31, 2018 | -$0.39 | N/A |
| Dec 31, 2017 | -$0.13 | -255.5% |
| Dec 31, 2016 | $0.08 | -38.7% |
| Dec 31, 2015 | $0.13 | N/A |
Frequently Asked Questions About CPHI
How often does CPHI beat earnings estimates?
China Pharma Holdings beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -3.08%.
CPHI pages: Overview, Earnings, Financials, Valuation, Competitors